Javascript must be enabled to continue!
Comparison of aprepitant and dexamethasone versus metoclorpramide and dexamethasone for prevention of post-operative nausea and vomiting in patients undergoing laparoscopic cholecystectomy.
View through CrossRef
Objective: To compare the efficacy of aprepitant and dexamethasone versus metoclopramide and dexamethasone combination in prevention of post-operative nausea and vomiting in females undergoing laparoscopic cholecystectomy. Study Design: Prospective Comparative study. Setting: Department of Anesthesia, CMH Lahore. Period: October 2019 to April 2020. Material & Methods: A total of 140 female patients planned for laparoscopic cholecystectomy under general anesthesia, of age ranges from 35-65 years and ASA classification I and II were recruited for the study and were divided into two equal groups. In group A (n=70), patients were given oral aprepitant 80 mg with once sip of water one hour prior to induction and dexamethasone 8 mg upon induction. In group M (n=70), patients were given a placebo one hour prior to induction and intravenous metoclopramide 10 mg and dexamethasone 8 mg upon induction. Results: Age range in this study was from 37 to 65 years with mean age of 46.82 ± 7.29 years. The mean age of patients in group A was 45.73 ± 6.77 years and in group M was 47.91 ± 7.66 years with p-value of 0.076. In our study, significant difference was found between the efficacy of two groups of drugs. The efficacy of aprepitant and dexamethasone was found in 62 (88.57%) patients, while with metoclopramide and dexamethasone, it was found in 51 (72.86%) patients with p-value of 0.031. Conclusion: it is concluded that aprepitant and dexamethasone combination has higher efficacy as compared to metoclorpromide and dexamethasone in prevention of post-operative nausea and vomiting in elective laparoscopic cholecystectomy.
Independent Medical Trust
Title: Comparison of aprepitant and dexamethasone versus metoclorpramide and dexamethasone for prevention of post-operative nausea and vomiting in patients undergoing laparoscopic cholecystectomy.
Description:
Objective: To compare the efficacy of aprepitant and dexamethasone versus metoclopramide and dexamethasone combination in prevention of post-operative nausea and vomiting in females undergoing laparoscopic cholecystectomy.
Study Design: Prospective Comparative study.
Setting: Department of Anesthesia, CMH Lahore.
Period: October 2019 to April 2020.
Material & Methods: A total of 140 female patients planned for laparoscopic cholecystectomy under general anesthesia, of age ranges from 35-65 years and ASA classification I and II were recruited for the study and were divided into two equal groups.
In group A (n=70), patients were given oral aprepitant 80 mg with once sip of water one hour prior to induction and dexamethasone 8 mg upon induction.
In group M (n=70), patients were given a placebo one hour prior to induction and intravenous metoclopramide 10 mg and dexamethasone 8 mg upon induction.
Results: Age range in this study was from 37 to 65 years with mean age of 46.
82 ± 7.
29 years.
The mean age of patients in group A was 45.
73 ± 6.
77 years and in group M was 47.
91 ± 7.
66 years with p-value of 0.
076.
In our study, significant difference was found between the efficacy of two groups of drugs.
The efficacy of aprepitant and dexamethasone was found in 62 (88.
57%) patients, while with metoclopramide and dexamethasone, it was found in 51 (72.
86%) patients with p-value of 0.
031.
Conclusion: it is concluded that aprepitant and dexamethasone combination has higher efficacy as compared to metoclorpromide and dexamethasone in prevention of post-operative nausea and vomiting in elective laparoscopic cholecystectomy.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Aprepitant Use in Pediatric Cyclical Vomiting Syndrome: A Systematic Review
Aprepitant Use in Pediatric Cyclical Vomiting Syndrome: A Systematic Review
Background: Cyclical vomiting syndrome (CVS) is a disorder of gut–brain interaction characterized by recurrent, stereotyped episodes of intense nausea and vomiting with return to b...
Aprepitant Inhibits JNK and p38/MAPK to Attenuate Inflammation in Microglia and Suppresses Inflammatory Pain
Aprepitant Inhibits JNK and p38/MAPK to Attenuate Inflammation in Microglia and Suppresses Inflammatory Pain
Abstract
Background: Substance P (SP) contributes to the pathogenesis of pain by acting on neurokinin‐1 receptor (NK-1R), specialized sensory neurons that detect noxious st...
Comparison of metoclopramide–dexamethasone combination and metoclopramide alone for prophylaxis of postoperative nausea vomiting in laparoscopic cholecystectomy
Comparison of metoclopramide–dexamethasone combination and metoclopramide alone for prophylaxis of postoperative nausea vomiting in laparoscopic cholecystectomy
BACKGROUND & OBJECTIVE: Post operative nausea and vomiting (PONV) is an important concern in laparoscopic surgeries. Aim of this study is to identify the role of metoclopramide...
Comparison of Single Clip Laparoscopic Cholecystectomy (SCLC) and Two Clip Laparoscopic Cholecystectomy (TCLC): A Randomized Control Study
Comparison of Single Clip Laparoscopic Cholecystectomy (SCLC) and Two Clip Laparoscopic Cholecystectomy (TCLC): A Randomized Control Study
Background: Advanced energy sources, such as the harmonic scalpel, though expensive, may provide the advantage of shorter operating time by reducing smoke, bloodless dissection in ...
Prevalence of Iatrogenic Bile Duct Injury Following Open and Laparoscopic Cholecystectomy Treatment Outcomes
Prevalence of Iatrogenic Bile Duct Injury Following Open and Laparoscopic Cholecystectomy Treatment Outcomes
Background and Aim:Iatrogenic bile duct injuries (IBDI) continue to be a difficult diagnostic and therapeutic problem. The prevalence of iatrogenic IBDI increased with the laparosc...
Midazolam versus Ondansetron versus Dexamethasone in Preventing Post-Operative Nausea and Vomiting after Elective Laparoscopic Abdominal Surgeries
Midazolam versus Ondansetron versus Dexamethasone in Preventing Post-Operative Nausea and Vomiting after Elective Laparoscopic Abdominal Surgeries
Abstract
Background
Laparoscopic surgery is associated with a remarkably high risk of post-operative nausea and vomiting. The re...
Use of palonosetron 0.25 mg IV daily and incidence of nausea and vomiting in patients undergoing bone marrow transplantation (BMT)
Use of palonosetron 0.25 mg IV daily and incidence of nausea and vomiting in patients undergoing bone marrow transplantation (BMT)
16510 Background: Preparative regimens for BMT are associated with a high incidence of nausea and vomiting, which can negatively affect quality of life. It is important to evaluat...

